Latigobio
Latigo Biotherapeutics is seeking a Senior Director, Scientific Communications to lead the development and execution of scientific communications strategy for its clinical-stage, non-opioid pain programs. This role involves translating emerging clinical and scientific evidence into compelling communications for healthcare professionals and stakeholders. The position requires strong scientific acumen and strategic thinking to manage publication planning, congress strategy, and core scientific materials.
Latigo Biotherapeutics is a biopharmaceutical company focused on developing non‑opioid therapies to relieve pain and restore health. Their approach targets the source of pain before it reaches the central nervous system, aiming to prevent chronic pain rather than merely dull symptoms. Latigo’s solutions are designed to enable healing without dependence and to provide durable relief that can help restore patients’ quality of life.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Latigobio.
20% above the average for this role
Senior Director, Medical and Scientific Communications
Vera Therapeutics, Inc.
Associate Director, Scientific Communications
Compass Pathways
Senior Manager, Scientific Communications
Azurity Pharmaceuticals
Associate Director of Scientific Communications
Beeline Medicines
Associate Director, Scientific Strategy & Publications
BridgeBio Pharma
Senior Manager/Associate Director, Scientific Communications
Avalyn Pharma